Trails Center.org

Clinical Trial Name -A Study to Evaluate the Effect of Nandrolone Decanoate in Women With HIV-Associated Weight Loss

 
Original Study ID : ACTG 329
NCT ID : NCT00000854
Brief Title : A Study to Evaluate the Effect of Nandrolone Decanoate in Women With HIV-Associated Weight Loss
Official Title : A Randomized, Double-Blind, Placebo-Controlled, Phase I/II Trial of Nandrolone Decanoate in Women With HIV-Associated Weight Loss
Brief Summary : The purpose of this study is to see if giving nandrolone decanoate (a hormonal drug) will cause weight gain in HIV-positive women who have HIV-associated weight loss (wasting). Wasting has become an AIDS-defining condition. In the past, most studies that examined wasting treatments were limited to men. However, it appears that wasting in HIV-positive men is linked to levels of testosterone (a hormone which affects men's bodies more than women's). This study has been designed for women only, in order to best treat wasting in HIV-positive women.
Source : National Institute of Allergy and Infectious Diseases (NIAID)
Detailed Description :
Body wasting is an increasingly frequent AIDS-defining condition and it is becoming evident
that women are not exempt from this complication of HIV.

Although multicenter trials of megestrol acetate, dronabinol and growth hormone have not
specifically excluded women, women have generally been underrepresented in these trials. This
study hopes to generate data that will be substantial enough to perform an analysis that
might determine whether there are gender-based differences in anabolic potential.

Patients will be randomized to receive either nandrolone decanoate or placebo every 2 weeks
for 12 weeks of the study. All patients who complete the first 12 weeks of the study will be
eligible to receive open-label nandrolone for the subsequent 12 weeks.
Overall Status : Completed
Start Date : December 1996
Official Title : Phase 1
Phase : Interventional
Study Design : Treatment, Parallel Assignment, Safety Study
Enrollment : 38
Verification Date : May 2005
First Received Date : November 2, 1999
Trial Eligibility
Criteria :
Inclusion Criteria

You may be eligible for this study if you:

- Are an HIV-positive woman over 13 years old (need consent if under 18).

- Have lost weight over the past 12 months.

- Are able to eat almost enough to maintain your current weight.

- Agree to practice abstinence or use effective methods of birth control.

- Are on a stable anti-HIV drug regimen or have not been on any anti-HIV drug regimen
for the past 30 days.

Exclusion Criteria

You will not be eligible for this study if you:

- Are allergic to nandrolone.

- Have a history of cervical cancer, diabetes, cardiomyopathy or congestive heart
failure, or are taking certain medications.

- Have an active opportunistic (HIV-associated) infection or another major illness
within 30 days of study entry.

- Have an abnormal PAP smear.

- Have difficulty eating (are on tube-feeding, for example).

- Have severe nausea, vomiting, or diarrhea.

- Have Kaposi's sarcoma (unless stable) or are receiving chemotherapy or radiation for
any type of cancer.

- Are pregnant or breast-feeding.
Gender : Female
Minimum Age : 13 Years
Maximum Age : N/A
Healthy Volunteers : No
Facilities
Facility Name : Univ of California / San Diego Treatment Ctr
City : San Diego
State : California
Zip Code : 921036325
Country : United States
Facility Name : San Francisco Gen Hosp
City : San Francisco
State : California
Zip Code : 941102859
Country : United States
Facility Name : UCLA CARE Ctr
City : Los Angeles
State : California
Zip Code : 90095
Country : United States
Facility Name : Univ of Southern California / LA County USC Med Ctr
City : Los Angeles
State : California
Zip Code : 900331079
Country : United States
Facility Name : Univ of Colorado Health Sciences Ctr
City : Denver
State : Colorado
Zip Code : 80262
Country : United States
Facility Name : Howard Univ
City : Washington
State : District of Columbia
Zip Code : 20059
Country : United States
Facility Name : Queens Med Ctr
City : Honolulu
State : Hawaii
Zip Code : 96816
Country : United States
Facility Name : Univ of Hawaii
City : Honolulu
State : Hawaii
Zip Code : 96816
Country : United States
Facility Name : Northwestern Univ Med School
City : Chicago
State : Illinois
Zip Code : 60611
Country : United States
Facility Name : Charity Hosp / Tulane Univ Med School
City : New Orleans
State : Louisiana
Zip Code : 70112
Country : United States
Facility Name : Johns Hopkins Hosp
City : Baltimore
State : Maryland
Zip Code : 21287
Country : United States
Facility Name : Beth Israel Deaconess - West Campus
City : Boston
State : Massachusetts
Zip Code : 02215
Country : United States
Facility Name : St Louis Regional Hosp / St Louis Regional Med Ctr
City : St. Louis
State : Missouri
Zip Code : 63112
Country : United States
Facility Name : Univ of Rochester Medical Center
City : Rochester
State : New York
Zip Code : 14642
Country : United States
Facility Name : Beth Israel Med Ctr
City : New York
State : New York
Zip Code : 10003
Country : United States
Facility Name : Univ of North Carolina
City : Chapel Hill
State : North Carolina
Zip Code : 275997215
Country : United States
Facility Name : Duke Univ Med Ctr
City : Durham
State : North Carolina
Zip Code : 27710
Country : United States
Facility Name : Univ of Cincinnati
City : Cincinnati
State : Ohio
Zip Code : 452670405
Country : United States
Facility Name : Univ of Pennsylvania at Philadelphia
City : Philadelphia
State : Pennsylvania
Zip Code : 19104
Country : United States
Facility Name : Julio Arroyo
City : West Columbia
State : South Carolina
Zip Code : 29169
Country : United States
Facility Name : Univ of Puerto Rico
City : San Juan
State : South Carolina
Zip Code : 009365067
Country : Puerto Rico
Refferances
Citation : Mulligan K, Zackin R, Clark RA, Sattler FR, Santana J, Delvers T, Currier JS. Nandrolone decanoate increases weight and lean body mass in HIV-infected women with weight loss: a randomized, double-blind, placebo-controlled, multicenter trial. 8th Conf Retro and Opportun Infect. 2001 Feb 4-8 (abstract no 641)
 
Search Trials By
Search
 
Research
 
 
Most Popular Trials
 
Library
 
Discuss